The Journal of Allergy and Clinical Immunology: In Practice
Review and Feature ArticleEnhancing Respiratory Medication Adherence: The Role of Health Care Professionals and Cost-Effectiveness Considerations
Key words
Abbreviations used
Cited by (0)
The Expert Adherence Panel Meeting from which the concepts presented in this article were first discussed and the manuscript submission costs were supported by the Respiratory Effectiveness Group. Teva supported the meeting costs at which the concepts in this paper were discussed by the co-authors and the open access publication fee for this article. The authors had full editorial control over the ideas presented.
Conflicts of interest: J. F. M. van Boven has received travel support from the Respiratory Effectiveness Group and European COPD Coalition; has received consultancy fees from AstraZeneca; and has received research support from AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim, and Chiesi. M. N. Eakin has received travel support from the Respiratory Effectiveness Group; has received consultancy fees from Boehringer Ingelhiem; has received research support from the National Institutes of Health, Cystic Fibrosis Foundation, and American Lung Association; and has received lecture fees from Praxis Pharmaceuticals. J. M. Foster has received travel support from the Respiratory Effectiveness Group and European Academy of Allergy and Clinical Immunology; is on the Vertex Pharmaceuticals advisory board; and has received research support from GlaxoSmithKline and AstraZeneca. The rest of the authors declare that they they have no relevant conflicts of interest.